Donor Umbilical Cord Blood Transplant With or Without Ex-vivo Expanded Cord Blood Progenitor Cells in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, or Myelodysplastic Syndromes

Key facts

Sponsor

Nohla Therapeutics, Inc.

Principal Investigator

Filippo Milano, M.D

Fred Hutch/University of Washington Cancer Consortium

Intervention

Cyclophosphamide(drug)

Enrollment

163 enrolled

Eligibility

65 years · All sexes

Timeline

2012 – 2020

Study locations (8)

• City of Hope Comprehensive Cancer Center, Duarte, California, United States
• Stanford Cancer Institute Palo Alto, Palo Alto, California, United States
• University of Colorado, Denver, Colorado, United States
• Dana-Farber Cancer Institute, Boston, Massachusetts, United States
• Mount Sinai Hospital, New York, New York, United States
• Duke University Medical Center, Durham, North Carolina, United States
• Cleveland Clinic Foundation, Cleveland, Ohio, United States
• Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Collaborators

National Cancer Institute (NCI) · National Heart, Lung, and Blood Institute (NHLBI)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute biphenotypic leukemia

Additional recruiting or active studies for the same condition.

• ENROLLING BY INVITATIONPHASE2NCT07517510
  HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).
  Guangdong Second Provincial General Hospital
• RECRUITINGPHASE1, PHASE2NCT07356154
  A Study of Revumenib and Mezigdomide in People With Leukemia
  Memorial Sloan Kettering Cancer Center
• RECRUITINGNCT07537738
  Leukemia Stem Cell-based Assay to Predict Relapse and Survival in Patients With Acute Myeloid Leukemia
  Peking University People's Hospital
• RECRUITINGPHASE1, PHASE2NCT05589896
  A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
  Ossium Health, Inc.
• RECRUITINGNANCT05794880
  MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
  Medical College of Wisconsin
• ACTIVE NOT RECRUITINGPHASE2NCT03399773
  Infusion of Expanded Cord Blood Cells in Addition to Single Cord Blood Transplant in Treating Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplastic Syndromes
  Fred Hutchinson Cancer Center
• RECRUITINGPHASE1, PHASE2NCT04797767
  Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms
  University of Washington
• ACTIVE NOT RECRUITINGPHASE2NCT04975919
  Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia
  M.D. Anderson Cancer Center

See all trials for Acute biphenotypic leukemia →